By: Ramin Skibba, Claire Cameron
Varda's plan to develop medicines in microgravity has its advantages, but it requires a big up-front cost
Ramin Skibba is a Science Writer and Freelance Journalist based in the Bay Area. He covers a diverse range of topics including technology, climate change, and sustainability, with a focus on computer hardware, telecommunications, and space travel. Ramin's work has been featured in prominent publications such as WIRED, National Geographic, and Rolling Stone.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston


Not enough data
Ramin Skibba's coverage mainly focuses on scientific themes, particularly space exploration and astronomy. He often cites data and government announcements in his articles, suggesting he is likely to respond positively to pitches that offer new scientific findings or access to experts with insights into the latest developments in space research, astronomy, telescopes, space missions, as well as moon and Mars exploration.
Given Ramin's interest in citing data and government announcements related to science topics such as space exploration, it would be beneficial for pitch ideas to include access to reliable sources of information or insights from reputable scientists or researchers involved in these fields.
This information evolves through artificial intelligence and human feedback. Improve this profile .